ROYAL BANK OF CANADA - MABVAX THERAPEUTICS HLDGS IN ownership

Back to all holdings Add to watchlist

MABVAX THERAPEUTICS HLDGS IN's ticker is MBVXQ and the CUSIP is 55414P702. A total of 2 filers reported holding MABVAX THERAPEUTICS HLDGS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of MABVAX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q2 2018$3,000
-40.0%
2,9990.0%0.00%–
Q1 2018$5,000–2,999–0.00%–
 Download
Other shareholders
MABVAX THERAPEUTICS HLDGS IN shareholders Q3 2018
NameSharesValueWeighting ↓
Biomark Capital Management Co. LLC 8,903$4,0000.04%
PANAGORA ASSET MANAGEMENT INC 26,382$11,0000.00%
View complete list of MABVAX THERAPEUTICS HLDGS IN shareholders